Literature DB >> 12011758

Proinflammation: a common denominator or initiator of different pathophysiological disease processes.

Tobias Esch1, George Stefano.   

Abstract

Proinflammation is a widespread phenomenon. It has an association with the stress (patho)physiology and is connected with various diseases. Recently, it has been discussed if proinflammation may represent a common (pre)condition in different disease states. Evidence for a common proinflammatory pattern in a variety of diseases is analyzed. Proinflammatory (pre)conditions and immune response patterns serve as a common modality in a number of clinically separate diseases. Here, nitric oxide pathways often play a significant role as well. On molecular basis, proinflammation potentially illustrates a common denominator and/or an initiator. Like stress, proinflammation seems to be a crucial autoregulatory concept. It normally serves a positive biological goal: Proinflammatory activities, e.g., are initiated to overcome infection or invasion of potentially deleterious biological agents (bacteria, viruses, parasites etc.). While fighting invasion, proinflammation usually shortens biological 'battles' and therefore ameliorates disease-related detrimental or subjectively unpleasing phenomena. However, proinflammation has beneficial and deteriorating capacities and may yet exert detrimental effects. This is especially true, when the fine balance between the different immune response pathways, between anti- and proinflammatory mechanisms, can not be kept. This may occur when a challenge becomes overwhelming or when patterns of a chronic (patho)physiological activity are presented. Thus, proinflammation may represent a relatively unspecific, overlapping/ analogous state, underlying various clinical disease manifestations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011758

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  28 in total

1.  Social isolation and adult mortality: the role of chronic inflammation and sex differences.

Authors:  Yang Claire Yang; Martha K McClintock; Michael Kozloski; Ting Li
Journal:  J Health Soc Behav       Date:  2013-05-06

2.  Putative Role of Cardio Metabolic Risk Among Poorly Controlled Asthmatics in South Indian Population.

Authors:  Murugaiyan Sathish Babu; K P Sreesoorya; Surendra K Menon; Subiman Saha; A R Srinivasan; S Arul Vijaya Vani; R Reeta; V Kuzhandai Velu
Journal:  Indian J Clin Biochem       Date:  2016-07-22

3.  Unraveling the mechanism of action of a new type III secretion system effector AexU from Aeromonas hydrophila.

Authors:  Johanna C Sierra; Giovanni Suarez; Jian Sha; Wallace B Baze; Sheri M Foltz; Ashok K Chopra
Journal:  Microb Pathog       Date:  2010-05-27       Impact factor: 3.738

4.  Aged mice have increased inflammatory monocyte concentration and altered expression of cell-surface functional receptors.

Authors:  Kelley Strohacker; Whitney L Breslin; Katie C Carpenter; Brian K McFarlin
Journal:  J Biosci       Date:  2012-03       Impact factor: 1.826

Review 5.  Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology.

Authors:  George B Stefano; Richard M Kream; Kirk J Mantione; Melinda Sheehan; Patrick Cadet; Wei Zhu; Thomas V Bilfinger; Tobias Esch
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

Review 6.  Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes.

Authors:  Marc Y Donath; Joachim Størling; Kathrin Maedler; Thomas Mandrup-Poulsen
Journal:  J Mol Med (Berl)       Date:  2003-07-18       Impact factor: 4.599

7.  Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation.

Authors:  Xin Shelley Wang; Qiuling Shi; Lori A Williams; Charles S Cleeland; Gary M Mobley; James M Reuben; Bang-Ning Lee; Sergio A Giralt
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

8.  Comparison of blood monocytes and adipose tissue macrophages in a mouse model diet-induced weight gain.

Authors:  Brian K McFarlin; Katie C Carpenter; Kelley Strohacker; Whitney L Breslin
Journal:  Comp Med       Date:  2012-12       Impact factor: 0.982

9.  Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity.

Authors:  O Osborn; S E Brownell; M Sanchez-Alavez; D Salomon; H Gram; T Bartfai
Journal:  Cytokine       Date:  2008-08-23       Impact factor: 3.861

10.  Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy.

Authors:  Suvi Liimatainen; Mahdi Fallah; Elham Kharazmi; Maria Peltola; Jukka Peltola
Journal:  J Neurol       Date:  2009-02-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.